Skip to main content
. 2021 Feb 11;147(9):2681–2691. doi: 10.1007/s00432-021-03544-3

Table 3.

Results of subgroups analyses

Groups Categories Number of studies Effect estimate P Heterogeneity with groups (I2) Pheterogeneity
Location North America 7 0.47 (0.33, 0.68)  < 0.001 53% 0.040
Europe 5 0.47 (0.18, 1.22) 0.120 89%  < 0.001
Follow-up period  ≤ 5 years 2 0.65 (0.50, 0.84) 0.001 4% 0.310
 > 5 years 4 0.48 (0.17, 1.31) 0.150 71% 0.020
Study design Case control 6 0.55 (0.25, 1.20) 0.130 87%  < 0.001
Cohort 6 0.55 (0.44, 0.69)  < 0.001 36% 0.160
Sample size  ≤ 1000 5 0.32 (0.11, 0.88) 0.030 83%  < 0.001
 > 1000 7 0.57 (0.39, 0.82) 0.003 69% 0.003
Adjusted confounders Multivariable-adjusted 10 0.46 (0.30, 0.71)  < 0.001 81%  < 0.001
Age-gender adjusted 2 0.09 (0.05, 0.17)  < 0.001 0% 0.340
Unadjusted 7 0.57 (0.41, 0.81) 0.002 59% 0.020
Quality assessment High 6 0.59 (0.47–0.74)  < 0.001 31% 0.200
Moderate 4 0.62 (0.18–2.14) 0.440 91%  < 0.001